Inhalation & Respiratory Drug Delivery 2019 Conference

30-31 May 2019 ∣ New York (USA)

 

On 30 & 31 May 2019, New York (USA) will host the BioTech Pharma Summit: Inhalation & Respiratory Drug Delivery 2019 conference. This year’s event is designed for senior industry experts that will showcase new trends in aerosol science and the future directions of inhalation drug delivery research. Further discussion focusses on the regulatory pathways for inhaled therapies and challenges of bringing respiratory products to market. The agenda also features key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy.

 

Over 200+ delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will be joining the Inhalation & Respiratory Drug Delivery 2019.

 

The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis.

 

The BioTech Pharma Summit: Inhalation & Respiratory Drug Delivery 2019 will focus on the challenges of bringing respiratory products to market and innovative aerosol science, including modelling and toxicology. Presentations will also feature key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis.

 

KEY PRACTICAL LEARNING POINTS

♦ Novel technologies for pulmonary & nasal delivery

♦ Innovative development of inhalation devices

♦ Improving patient adherence with product design

♦ Digital health combination products

♦ Inhaled vaccines

♦ New trends in combination product design

♦ Analytical tools for inhaled medicines

♦ Challenges of bringing inhalation and respiratory drug delivery products to market

♦ Regulatory updates in the global respiratory market

♦ The challenge of developing inhalation devices

♦ Alternative therapeutic fields: inhaled antibiotics

♦ Dry-powder inhalers (DPIs)

♦ Aerosol Science & Particle Engineering

♦ Metered-dose inhalers (MDIs)

♦ Routes to controlling aerosol response

♦ Characterising aerosol dynamics

♦ Model validation

♦ Future directions in inhalation and respiratory drug delivery research

♦ Improving patient adherence with product design

♦ Establishing clear relationships between in vitro and in vivo data

♦ Particle engineering including spray drying

♦ Connective Health/ E Health

♦ Regulatory pathways for inhaled therapies

♦ Analytical tools for inhaled medicines

♦ Clinical Areas COPD, Asthma, Diabetes, Cystic Fibrosis

♦ Challenges of developing a generic inhaled product

♦ Alternative therapeutic fields:

♦ Inhaled insulin

 

Contact us
 
Diogo Lino Ribeiro
Tel: +351 915 239 640
Email: diogo.ribeiro@epmgroup.org
Conference website: https://biotechpharmasummit.com/index.php/event/inhalation-respiratory-drug-delivery-2019/